J B CHEMICALS AND PHARMA

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Institution of new Employee Stock Option Scheme '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'ANDA Approval by US FDA'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Result of Postal Ballot '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Issue of Postal Ballot Notice '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Newspaper publication'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Resignation of Independent Directors'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Change in Board of Directors'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015-Open Offer by Tau Investment Holdings Pte. Ltd.-Extension of time for dispatch of Letter of Offer granted by SEBI'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015-Purchase of Pharmaceutical Business Undertaking of Lekar Pharma Limited'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Submission of recommendation of Committee of Independent Directors ( IDC ) under Regulation 26(7) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, as amended.'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015-Notice of Annual General Meeting '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015-Notice in respect of transfer of equity shares of the Company to Investor Education and Protection Fund (IEPF).'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 -Prior Public Notice for Equity Shareholders of the Company with regard to convening of AGM through Video Conferencing (VC)/Other Audio Visual Means (OAVM).'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Purchase of Pharmaceutical Business Undertaking of Lekar Pharma Limited'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Public Announcement of open offer for acquisition of Company s Equity Shares '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'ANDA approval by US FDA '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Contribution to PM Cares Fund'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 -Supreme Court judgement on orders passed by National Green Tribunal'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'News about Ranitidine formulations in the US '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'US FDA approval of New Solid Oral dosage forms formulations manufacturing facility at Panoli, Gujarat'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Successful US FDA inspection of Solid Oral dosage forms formulations manufacturing facility at Panoli, Gujarat'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Acquisition of trademarks '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Regulatory one-time increase in price of Metronidazole formulations'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Approval for re-classification of certain promoter group members to public'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'copy of Board Resolution pursuant to the provisions of SEBI (Buy-Back of Securities) Regulation, 2018'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Detailed reason for resignation and confirmation by Independent director'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'News about presence of NDMA in Ranitidine'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Submission of application for re-classification under Regulation 31A of the Listing Regulations'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations).'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Notice of Annual General Meeting '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Regulations and Disclosure Requirements), 2015 and Code for fair disclosure of UPSI'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Successful US FDA inspection of new Solid Oral dosage forms formulations manufacturing facility at Panoli, Gujarat'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Notice in respect of transfer of equity shares of the Company to Investor Education and Protection Fund (IEPF).'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Intimation pursuant to Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure of receipt of request from the promoter group member seeking re-classification of status as public'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure of receipt of request from the promoter group member seeking re-classification of status as public'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure of receipt of requests from the promoter group members seeking re-classification of status as public'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Regulations and Disclosure Requirements), 2015 read with SEBI Circular CIR/CFD/CMD/4/2015 dated 09-09-2015'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Regulations and Disclosure Requirements), 2015 read with SEBI Circular CIR/CFD/CMD/4/2015 dated 09-09-2015'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'ANDA approval by US FDA'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Pre-approval inspection by US FDA '.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Letter of Offer -Proposed Buyback of Company'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Buy-back updates: Filing of Draft Letter of Offer'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Successful US FDA inspection of Solid Oral dosage forms formulations manufacturing facility at Panoli, Gujarat'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Sub : Notice of Annual General Meeting In compliance with the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the notice of the Annual General Meeting of the Company to be held on September 4, 2018.'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Regulations and Disclosure Requirements), 2015Ref: Update on Explosion/Fire at API Plant at Panoli, Gujarat'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Sub: Disclosure under Regulation 30 of SEBI (Listing Regulations and Disclosure Requirements), 2015Ref: Explosion/Fire at API Plant at Panoli, GujaratThis is to inform you that one reactor has exploded/caught fire this morning at Company��s API manufacturing unit at Panoli, Gujarat in the course of manufacturing process. This has damaged surrounding civil structure and equipment. The extent of damage/loss is not known at present. The buildings and plant and machinery at the said unit are fully covered by insurance. We